Filing Flows › biote (BTMD) › Q3 2026 › vs Q3 2025
biote (BTMD) Q3 2026 vs Q3 2025 (year over year)
biote's revenue fell $4.6M (-10%) from $48.0M in Q3 2025 to $43.3M in Q3 2026. The biggest changes: Product revenue −$4.4M (-9%); Service revenue −$238K (-24%). Operating margin 5.7% against 17.2% (-11.5 pts).
biote, Q3 2026: revenue $43.3M (-10% year over year), operating margin 5.7%, net earnings $407K, operating cash flow $3.7M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 5.7% | 17.2% | -11.5 pts |
| Net margin | 0.9% | 17.1% | -16.1 pts |
| Free cash flow margin | 2.6% | 28.3% | -25.7 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product revenue | $42.6M | $47.0M | −$4.4M | -9% |
| Service revenue | $765K | $1.0M | −$238K | -24% |
| Revenue | $43.3M | $48.0M | −$4.6M | -10% |
| Operating profit | $2.5M | $8.3M | −$5.8M | -70% |
| Costs & expenses | $40.8M | $39.7M | $1.2M | +3% |
| Pre-tax earnings | $1.4M | $8.5M | −$7.1M | -84% |
| Other expense, net | $1.1M | −$184K | $1.3M | — |
| Cost of revenue | $14.0M | $13.5M | $465K | +3% |
| SG&A | $26.8M | $26.2M | $693K | +3% |
| Net earnings | $407K | $8.2M | −$7.8M | -95% |
| Minority interests | $162K | $1.0M | −$866K | -84% |
| Income tax | $796K | −$765K | $1.6M | — |
| Depreciation & amortization | $1.0M | $952K | $76K | +8% |
| Share-based compensation | $1.3M | $2.4M | −$1.1M | -44% |
| Working capital & other | $909K | $2.5M | −$1.6M | -64% |
| Operating cash flow | $3.7M | $14.1M | −$10.4M | -74% |
| Free cash flow (OCF − capex) | $1.1M | $13.6M | −$12.5M | -92% |
| Capital expenditures | $2.6M | $499K | $2.1M | +416% |
Questions
How much did biote's revenue grow year over year in Q3 2026?
biote's revenue fell $4.6M (-10%) from $48.0M in Q3 2025 to $43.3M in Q3 2026.
What drove biote's revenue change in Q3 2026?
Product revenue −$4.4M (-9%); Service revenue −$238K (-24%).